Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3658)
All Articles published online
|
Dec 21, 2009 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(47): 5983-5991 [PMID: 20014464 DOI: 10.3748/wjg.15.5983] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i47/5983.htm |
| Number | Citing Articles |
| 1 |
Kosuke Narumiya, Ralf Metzger, Elfriede Bollschweiler, Hakan Alakus, Jan Brabender, Uta Drebber, Arnulf H Hölscher, Ute Warnecke-Eberz.
Impact of
ABCB1
C3435T Polymorphism on Lymph node Regression in Multimodality Treatment of Locally Advanced Esophageal Cancer
. Pharmacogenomics 2011; 12(2): 205 doi: 10.2217/pgs.10.174
|
| 2 |
M Kranzfelder, T Schuster, H Geinitz, H Friess, P Büchler. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. British Journal of Surgery 2011; 98(6): 768 doi: 10.1002/bjs.7455
|
| 3 |
Daniel Vallböhmer, Jan Brabender, Peter Grimminger, Wolfgang Schröder, Arnulf H Hölscher. Predicting response to neoadjuvant therapy in esophageal cancer. Expert Review of Anticancer Therapy 2011; 11(9): 1449 doi: 10.1586/era.11.126
|
| 4 |
Daniel Lin, Lawrence Leichman. The Current Status of Neoadjuvant Therapy for Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery 2014; 26(2): 102 doi: 10.1053/j.semtcvs.2014.07.002
|
| 5 |
K. Maruyama, S. Motoyama, A. Anbai, S. Usami, Y. Sato, K. Shibuya, K. Yoshino, T. Nakatsu, Y. Minamiya, J.-I. Ogawa. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. Diseases of the Esophagus 2011; 24(3): 166 doi: 10.1111/j.1442-2050.2010.01119.x
|
| 6 |
William S. Twaddell, Peter C. Wu, Roy J.J. Verhage, Marcus Feith, David H. Ilson, Christoph P. Schuhmacher, James D. Luketich, Björn Brücher, Daniel Vallböhmer, Wayne L. Hofstetter, Mark Jonathan Krasna, Daniela Kandioler, Paul M. Schneider, Bas P.L. Wijnhoven, Stephen J. Sontag. Barrett's esophagus: treatments of adenocarcinomas II. Annals of the New York Academy of Sciences 2011; 1232(1): 265 doi: 10.1111/j.1749-6632.2011.06056.x
|
| 7 |
Luis F. Tapias, Christopher R. Morse. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery Alone. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2011; 6(5): 331 doi: 10.1097/imi.0b013e3182364e5d
|
| 8 |
Kazuki Ishikawa, Kiyoshi Nakamatsu, Osamu Shiraishi, Takushi Yasuda, Yasumasa Nishimura. Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer. International Journal of Clinical Oncology 2015; 20(3): 531 doi: 10.1007/s10147-014-0736-9
|
| 9 |
Bryan H. Burmeister, Janine M. Thomas, Elizabeth A. Burmeister, Euan T. Walpole, Jennifer A. Harvey, Damien B. Thomson, Andrew P. Barbour, David C. Gotley, B. Mark Smithers. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. European Journal of Cancer 2011; 47(3): 354 doi: 10.1016/j.ejca.2010.09.009
|
| 10 |
Marjolein Y.V. Homs, Martijn G.H. van Oijen, Bas P.L. Wijnhoven, Richard van Hillegersberg, Maureen de Boer-Dennert, Peter D. Siersema. Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009. European Journal of Gastroenterology & Hepatology 2012; 24(2): 126 doi: 10.1097/MEG.0b013e32834e7f29
|
| 11 |
Meike M.C. Hirdes, Peter Siersema. Endoprosthetics for malignant esophageal disease. Techniques in Gastrointestinal Endoscopy 2014; 16(2): 64 doi: 10.1016/j.tgie.2014.07.004
|
| 12 |
Mark D. Iannettoni. Invited Commentary. The Annals of Thoracic Surgery 2011; 92(6): 2040 doi: 10.1016/j.athoracsur.2011.09.041
|
| 13 |
Geertjan van Tienhoven, Dirk J. Gouma, Dick J. Richel. Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma. Therapeutic Advances in Medical Oncology 2011; 3(1): 27 doi: 10.1177/1758834010383150
|
| 14 |
K Kumagai, I Rouvelas, J A Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, L Lundell, M Nilsson. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. British Journal of Surgery 2014; 101(4): 321 doi: 10.1002/bjs.9418
|
| 15 |
J. Straatman, P. J. M. Joosten, C. B. Terwee, M. A. Cuesta, E. P. Jansma, D. L. van der Peet. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer. Diseases of the Esophagus 2016; 29(7): 760 doi: 10.1111/dote.12405
|
| 16 |
Amin Doosti-Irani, Mohammad Ali Mansournia, Abbas Rahimi-Foroushani, Peiman Haddad, Kourosh Holakouie-Naieni. Local recurrence of esophageal squamous cell carcinoma after treatment: Comparison of frequentist and Bayesian network meta-analysis. Clinical Epidemiology and Global Health 2019; 7(2): 145 doi: 10.1016/j.cegh.2018.02.009
|
| 17 |
Li-Li Zhu, Ling Yuan, Hui Wang, Lin Ye, Gui-Ying Yao, Cui Liu, Niu-Niu Sun, Xiao-Jing Li, Shi-Cong Zhai, Ling-Juan Niu, Jun-Bo Zhang, Hong-Long Ji, Xiu-Min Li, Kevin Camphausen. A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer. PLOS ONE 2015; 10(6): e0128616 doi: 10.1371/journal.pone.0128616
|
| 18 |
A. van Nunen, M.J.C. van der Sangen, M. van Boxtel, P.M.A. van Haaren. Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy. Technical Innovations & Patient Support in Radiation Oncology 2017; : 30 doi: 10.1016/j.tipsro.2017.07.002
|
| 19 |
Bin Zheng, Wei Zheng, Yong Zhu, Xiao-yan Lin, Ben-hua Xu, Chun Chen. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis. Chinese Medical Journal 2013; 126(6): 1178 doi: 10.3760/cma.j.issn.0366-6999.20121798
|
| 20 |
Laurent Bedenne, Julie Vincent, Jean-Louis Jouve. Is surgery always necessary in esophageal cancer?. Esophagus 2011; 8(1): 3 doi: 10.1007/s10388-011-0258-8
|
| 21 |
Amy M. Buckley, Margaret R. Dunne, Niamh Lynam-Lennon, Susan A. Kennedy, Aoife Cannon, Alison L. Reynolds, Stephen G. Maher, John V. Reynolds, Breandán N. Kennedy, Jacintha O'Sullivan. Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma. Cancer Letters 2019; 447: 115 doi: 10.1016/j.canlet.2019.01.009
|
| 22 |
A. H. Hölscher, E. Bollschweiler. Early Gastrointestinal Cancers. Recent Results in Cancer Research 2012; 196: 169 doi: 10.1007/978-3-642-31629-6_11
|
| 23 |
K. Ott, L. Sisic, M. Büchler. Plattenepithelkarzinom des Ösophagus. Der Chirurg 2011; 82(11): 974 doi: 10.1007/s00104-011-2128-2
|
| 24 |
Masanobu Nakajima, Hiroyuki Kato. Treatment options for esophageal squamous cell carcinoma. Expert Opinion on Pharmacotherapy 2013; 14(10): 1345 doi: 10.1517/14656566.2013.801454
|
| 25 |
Yu-Zhen Zheng, Wei Zhao, Yi Hu, Xiao-Xiao Ding-Lin, Jing Wen, Hong Yang, Qian-Wen Liu, Kong-Jia Luo, Qing-Yuan Huang, Jun-Ying Chen, Jian-Hua Fu. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World Journal of Gastroenterology 2015; 21(28): 8644-8652 doi: 10.3748/wjg.v21.i28.8644
|
| 26 |
Haiming Feng, Ye Zhao, Tao Jing, Jianxing Ma, Yinglu Zhao, Jianhua Zhang, Cheng Wang, Bin Li. Traditional and cumulative meta‑analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma. Molecular and Clinical Oncology 2017; doi: 10.3892/mco.2017.1534
|
| 27 |
Yasunori Akutsu, Shigeo Yasuda, Matsuo Nagata, Yosuke Izumi, Shinichi Okazumi, Hideaki Shimada, Yukio Nakatani, Hirohiko Tsujii, Tadashi Kamada, Shigeru Yamada, Hisahiro Matsubara. A phase I/II clinical trial of preoperative short‐course carbon‐ion radiotherapy for patients with squamous cell carcinoma of the esophagus. Journal of Surgical Oncology 2012; 105(8): 750 doi: 10.1002/jso.22127
|
| 28 |
Amy M. Buckley, Niamh Lynam-Lennon, Susan A. Kennedy, Margaret R. Dunne, John J. Aird, Emma K. Foley, Niamh Clarke, Narayanasamy Ravi, Dermot O’Toole, John V. Reynolds, Breandán N. Kennedy, Jacintha O’Sullivan. Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma. Oncotarget 2018; 9(72): 33634 doi: 10.18632/oncotarget.25950
|
| 29 |
Cheng-Che Tu, Po-Kuei Hsu. Current choices and prospects in management of postoperative esophageal cancer patients. Asian Journal of Surgery 2019; 42(1): 81 doi: 10.1016/j.asjsur.2018.06.009
|
| 30 |
Sebastien Gilbert, Gillian K. Gresham, Derek J. Jonker, Andrew J. Seely, Donna E. Maziak, Farid M. Shamji, Jason Pantarotto, Sudhir Sundaresan. Impact of Patient Selection, Disease Progression, and Adverse Events on Esophageal Cancer Outcomes After Trimodality Therapy. The Annals of Thoracic Surgery 2012; 94(5): 1659 doi: 10.1016/j.athoracsur.2012.05.044
|
| 31 |
Dong-Bin Wang, Zhong-Yi Sun, Li-Min Deng, De-Qing Zhu, Hong-Gang Xia, Peng-Zhi Zhu. Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma. Chinese Medical Journal 2016; 129(24): 2974 doi: 10.4103/0366-6999.195464
|
| 32 |
Cengiz Gemici, Gokhan Yaprak, Hasan Fevzi Batirel, Mahmut Ilhan, Alpaslan Mayadagli. Radiation field size and dose determine oncologic outcome in esophageal cancer. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-1024-0
|
| 33 |
Alex G. Little, Antoon E. Lerut, David H. Harpole, Wayne L. Hofstetter, John D. Mitchell, Nasser K. Altorki, Mark J. Krasna. The Society of Thoracic Surgeons Practice Guidelines on the Role of Multimodality Treatment for Cancer of the Esophagus and Gastroesophageal Junction. The Annals of Thoracic Surgery 2014; 98(5): 1880 doi: 10.1016/j.athoracsur.2014.07.069
|
| 34 |
Yunpeng Zhao, Yongqiang Wang, Lei Shan, Chuanliang Peng, Wenhao Zhang, Xiaogang Zhao. A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86102-8
|
| 35 |
Keiichi Jingu, Hisanori Ariga, Kenji Nemoto, Kakutaro Narazaki, Rei Umezawa, Ken Takeda, Masashi Koto, Toshiyuki Sugawara, Masaki Kubozono, Go Miyata, Ko Onodera, Shogo Yamada. Long-Term Results of Radiochemotherapy for Solitary Lymph Node Metastasis After Curative Resection of Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics 2012; 83(1): 172 doi: 10.1016/j.ijrobp.2011.06.1978
|
| 36 |
Fang Li, Tao Li, Li Liu, Jiahua Lv, Yanqiong Song, Churong Li, Peng Diao. Concurrent versus Sequential Chemoradiotherapy for Esophageal Cancer among Chinese Population: A Meta-Analysis. Tumori Journal 2015; 101(4): 353 doi: 10.5301/tj.5000314
|
| 37 |
Karsten Bartels, Matthew Fiegel, Quinn Stevens, Bryan Ahlgren, Nathaen Weitzel. Approaches to Perioperative Care for Esophagectomy. Journal of Cardiothoracic and Vascular Anesthesia 2015; 29(2): 472 doi: 10.1053/j.jvca.2014.10.029
|
| 38 |
Luis F. Tapias, Douglas J. Mathisen, Cameron D. Wright, John C. Wain, Henning A. Gaissert, Ashok Muniappan, Michael Lanuti, Dean M. Donahue, Christopher R. Morse. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy. The Annals of Thoracic Surgery 2016; 101(3): 1097 doi: 10.1016/j.athoracsur.2015.09.062
|
| 39 |
Marcus W. Wiedmann, Joachim Mössner. International Manual of Oncology Practice. 2015; : 201 doi: 10.1007/978-3-319-21683-6_10
|
| 40 |
Ravi Shridhar, Khaldoun Almhanna, Sarah E. Hoffe, Matthew Biagioli, Domenico Coppola, Kenneth L. Meredith. The American Cancer Society's Oncology in Practice. 2018; : 33 doi: 10.1002/9781118592168.ch3
|
| 41 |
Ravi Shridhar, Reza Imani-Shikhabadi, Bonnie Davis, Oscar A. Streeter, Charles R. Thomas. Curative Treatment of Esophageal Cancer; An Evidenced Based Review. Journal of Gastrointestinal Cancer 2013; 44(4): 375 doi: 10.1007/s12029-013-9511-9
|
| 42 |
Kelvin K. W. Chan, Ronak Saluja, Keemo Delos Santos, Kelly Lien, Keya Shah, Gemma Cramarossa, Xiaofu Zhu, Rebecca K.S. Wong. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis. International Journal of Cancer 2018; 143(2): 430 doi: 10.1002/ijc.31312
|
| 43 |
Ravi Shridhar, Khaldoun Almhanna, Kenneth L. Meredith, Matthew C. Biagioli, Michael D. Chuong, Alex Cruz, Sarah E. Hoffe. Radiation Therapy and Esophageal Cancer. Cancer Control 2013; 20(2): 97 doi: 10.1177/107327481302000203
|
| 44 |
Reema Goel, Rathan M. Subramaniam, Jason W. Wachsmann. PET/Computed Tomography Scanning and Precision Medicine. PET Clinics 2017; 12(4): 373 doi: 10.1016/j.cpet.2017.05.001
|
| 45 |
Christine Kestens, Richard van Hillegersberg, Peter Siersema. Ontwikkelingen in de oncologie. 2014; : 231 doi: 10.1007/978-90-368-0436-3_24
|
| 46 |
Deirdre J Cohen, Jaffer Ajani. An expert opinion on esophageal cancer therapy. Expert Opinion on Pharmacotherapy 2011; 12(2): 225 doi: 10.1517/14656566.2010.517748
|
| 47 |
Mark Stavas, A. Bapsi Chakravarthy. Esophageal Cancer. 2015; : 157 doi: 10.1007/978-3-319-20068-2_10
|
| 48 |
Basil S. Nasir, Moishe Liberman. Difficult Decisions in Thoracic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach 2014; 1: 287 doi: 10.1007/978-1-4471-6404-3_23
|
| 49 |
Peter S. N. van Rossum, Richard van Hillegersberg, Frederiek M. Lever, Irene M. Lips, Astrid L. H. M. W. van Lier, Gert J. Meijer, Maarten S. van Leeuwen, Marco van Vulpen, Jelle P. Ruurda. Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?. European Radiology 2013; 23(7): 1753 doi: 10.1007/s00330-013-2773-6
|
| 50 |
Pierfrancesco Franco, Alba Fiorentino, Francesco Dionisi, Michele Fiore, Silvia Chiesa, Stefano Vagge, Francesco Cellini, Luciana Caravatta, Mario Tombolini, Fiorenza De Rose, Icro Meattini, Gianluca Mortellaro, Giuseppina Apicella, Lorenza Marino, Daniela Greto. Combined Modality Therapy for Thoracic and head and Neck Cancers: A Review of Updated Literature Based on a Consensus Meeting. Tumori Journal 2016; 102(5): 459 doi: 10.5301/tj.5000525
|
| 51 |
Kaushik Mukherjee, A. Bapsi Chakravarthy, Laura W. Goff, Wael El-Rifai. Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy. Digestive Diseases and Sciences 2010; 55(12): 3304 doi: 10.1007/s10620-010-1187-4
|
| 52 |
Xavier Cuenca, Christophe Hennequin, Elif Hindié, Sofia Rivera, Laetitia Vercellino, Valérie Baruch-Hennequin, Jean-Marc Gornet, Pierre Cattan, Mircea Chirica, Laurent Quéro. Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas. European Journal of Nuclear Medicine and Molecular Imaging 2013; 40(4): 477 doi: 10.1007/s00259-012-2325-3
|
| 53 |
Han-Ting Zhu, Da-Shan Ai, Hua-Rong Tang, Harun Badakhshi, Jian-Hong Fan, Jia-Ying Deng, Jun-Hua Zhang, Yun Chen, Zhen Zhang, Yi Xia, Xiao-Mao Guo, Guo-Liang Jiang, Kuai-Le Zhao. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World Journal of Gastroenterology 2017; 23(3): 540-546 doi: 10.3748/wjg.v23.i3.540
|
| 54 |
Amy M. Buckley, Becky AS. Bibby, Margaret R. Dunne, Susan A. Kennedy, Maria B. Davern, Breandán N. Kennedy, Stephen G. Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals 2019; 12(1): 33 doi: 10.3390/ph12010033
|
| 55 |
Neil Bryan Newman, A. Bapsi Chakravarthy. Esophageal Cancer. 2020; : 199 doi: 10.1007/978-3-030-29832-6_10
|
| 56 |
Felice Pasini, Anna Paola Fraccon, Giovanni de Manzoni. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma. Updates in Surgery 2012; : 131 doi: 10.1007/978-88-470-2330-7_12
|
| 57 |
M. Hingorani, T. Crosby, A. Maraveyas, S. Dixit, A. Bateman, R. Roy. Neoadjuvant Chemoradiotherapy for Resectable Oesophageal and Gastro-oesophageal Junction Cancer—Do We Need Another Randomised Trial?. Clinical Oncology 2011; 23(10): 696 doi: 10.1016/j.clon.2011.05.005
|
| 58 |
R. J. L. F. Loffeld, P. E. P. Dekkers. Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice. ISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/205417
|
| 59 |
Lindsay Danielle Kumble, Elisabeth Silver, Aaron Oh, Julian A Abrams, Joshua R Sonett, Chin Hur. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World Journal of Meta-Analysis 2019; 7(9): 406-417 doi: 10.13105/wjma.v7.i9.406
|
| 60 |
Christine Kestens, Richard van Hillegersberg, Peter Siersema. Oesofaguscarcinoom. Huisarts en wetenschap 2014; 57(1): 34 doi: 10.1007/s12445-014-0015-z
|
| 61 |
Luis F. Tapias, Christopher R. Morse. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery Alone. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2011; 6(5): 331 doi: 10.1177/155698451100600508
|
| 62 |
O. Dupuis, G. Ganem, G. Béra, Y. Pointreau, O. Pradier, P. Martin, X. Mirabel, F. Denis. Cancer de l’œsophage. Cancer/Radiothérapie 2010; 14: S74 doi: 10.1016/S1278-3218(10)70010-X
|
| 63 |
Ryan P. Merkow, Karl Y. Bilimoria, Martin D. McCarter, Warren B. Chow, Clifford Y. Ko, David J. Bentrem. Use of Multimodality Neoadjuvant Therapy for Esophageal Cancer in the United States: Assessment of 987 Hospitals. Annals of Surgical Oncology 2012; 19(2): 357 doi: 10.1245/s10434-011-1945-3
|
| 64 |
Peng Jin, Astrid van der Horst, Rianne de Jong, Jeanin E. van Hooft, Martijn Kamphuis, Niek van Wieringen, Melanie Machiels, Arjan Bel, Maarten C.C.M. Hulshof, Tanja Alderliesten. Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer. Radiotherapy and Oncology 2015; 117(3): 412 doi: 10.1016/j.radonc.2015.10.005
|
| 65 |
Jiaying Deng, Chunyu Wang, Mingqiong Xiang, Fatao Liu, Yun Liu, Kuaile Zhao. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-151
|
| 66 |
Arnulf H. Hölscher, Ulrich K. Fetzner. Multimodale Therapie mit kurativem Ansatz. Viszeralmedizin 2012; 28(2): 113 doi: 10.1159/000338283
|
| 67 |
Lei Jiang, Ke-hu Yang, Quan-lin Guan, Yan Chen, Peng Zhao, Jin-hui Tian. Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction. Journal of Clinical Gastroenterology 2015; 49(5): 387 doi: 10.1097/MCG.0000000000000212
|
| 68 |
Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi. Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis. Digestive Diseases and Sciences 2012; 57(12): 3226 doi: 10.1007/s10620-012-2263-8
|
| 69 |
Aminah Jatoi, Gamini Soori, Nathan R. Foster, Bradley K. Hiatt, James A. Knost, Tom R. Fitch, Matthew D. Callister, Francis C. Nichols, Tim M. Husted, Steven R. Alberts. Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors. Journal of Thoracic Oncology 2010; 5(12): 1994 doi: 10.1097/JTO.0b013e3181fb5c3e
|
| 70 |
Yaping Xu, Xinmin Yu, Qixun Chen, Weimin Mao. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-173
|
| 71 |
H X Yang, W Feng, J C Wei, T S Zeng, Z D Li, L J Zhang, P Lin, R Z Luo, J H He, J H Fu. Support vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinoma. British Journal of Cancer 2013; 109(5): 1109 doi: 10.1038/bjc.2013.379
|
| 72 |
J. Stiekema, H. Boot, B.M.P. Aleman, L.F.A. Wessels, J.W. van Sandick. Prognostication and prediction using gene expression profiling in oesophageal cancer. European Journal of Surgical Oncology (EJSO) 2013; 39(1): 17 doi: 10.1016/j.ejso.2012.07.008
|
| 73 |
Leila Sisic, Susanne Blank, Wilko Weichert, Dirk Jäger, Christoph Springfeld, Marcel Hochreiter, Markus Büchler, Katja Ott. Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG). Langenbeck's Archives of Surgery 2013; 398(7): 973 doi: 10.1007/s00423-013-1101-6
|
| 74 |
Nathan W. Bronson, Renato A. Luna, John G. Hunter. Tailoring Esophageal Cancer Surgery. Seminars in Thoracic and Cardiovascular Surgery 2012; 24(4): 275 doi: 10.1053/j.semtcvs.2012.11.001
|
| 75 |
|
| 76 |
Magali Cabau, Guillaume Luc, Eric Terrebonne, Geneviève Belleanne, Véronique Vendrely, Antonio Sa Cunha, Denis Collet. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma. The American Journal of Surgery 2013; 205(6): 711 doi: 10.1016/j.amjsurg.2012.08.009
|
| 77 |
Peter D. Siersema, Frank P. Vleggaar. Esophageal strictures, tumors, and fistulae: alternative techniques for palliating primary esophageal cancer. Techniques in Gastrointestinal Endoscopy 2010; 12(4): 203 doi: 10.1016/j.tgie.2011.02.015
|
| 78 |
Ranjit Joseph, Shachar Laks, Michael Meyers, Autumn J. McRee. Multidisciplinary Approach to the Management of Esophageal Malignancies. World Journal of Surgery 2017; 41(7): 1726 doi: 10.1007/s00268-017-4009-4
|